Diabetes in Control interviewed Novocells’ Chief Scientific Officer, Emmanual Baetge and he told us that they have determined the necessary conditions for turning human embryonic stem cells into insulin-producing cells, a finding that moves the prospect of using these cells to treat diabetes closer to the clinic.

A new drug billed as a magic bullet for obesity — rimonabant (Acomplia) — does help people lose weight, although not that much weight, and also helps lower cardiac risk factors, according to a review of studies.

Study finds a sixfold higher threat of pulmonary embolism after hip or knee replacements.

Breast-feeding is inversely associated with the risk of childhood obesity regardless of maternal diabetes status or weight status.

Metformin taken by women with polycystic ovary syndrome (PCOS) during the first trimester of pregnancy does not appear to increase the risk of major fetal malformations, and may have a significant protective effect.

Treating fasting blood sugars when the A1c is elevated, has a greater impact on the resulting A1c.

Treatment of postprandial hyperglycemia with acarbose did not prevent or delay disease progression in patients with early type 2 diabetes.

If French scientists are to be believed being obese is linked to a decline in a person’s cognitive function.

Results of a study provide more evidence for an association between use of second-generation antipsychotic drugs — in this case olanzapine, quetiapine, and risperidone — and the onset of diabetes.

Too little sleep may explain soaring levels of obesity in children, according to a scientist from Bristol University.